Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Miranda Davies
Chief Medical Officer
Drug Safety Research Unit, Southampton, UK, United Kingdom
Poster(s):
(333) Case Series Analysis of Immune-Mediated Neurological Events in Vaccinees following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(338) Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(349) Observed versus Expected Analysis of Adverse Events of Special Interest after AZD1222 (ChAdOx1 nCoV-19) Vaccination: Results from a UK Post-authorisation Active Surveillance Study
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
